Our client engaged MarketsandMarkets to grow revenues. For this purpose, we offered insights into the market value of 6mV single-photon radiotherapy systems in developing countries through end-user perception analysis, i.e., knowing the adoption pattern of these systems across end users. We also provided in-depth intelligence across the interconnections between client’s clients and their clients for early identification of latent opportunities. Our team defined and solved a series of problems that helped the client to strategize a roadmap to revenue impact. Few of the key problems solved during this engagement are:
Our team leveraged our AI-driven market intelligence platform, KnowledgeStore, for identifying key players of 6mV single-photon radiotherapy systems that were changing the revenue mix of our client’s clients in end-use industries such as radiotherapy centers and cancer specialty hospitals across South America, Eastern Europe, Asia, and Africa. We further carried out an end-user perception analysis by interviewing a host of potential end-users to understand the adoption pattern and growth perceptive of 6mV systems, key players of the market, preference of patients for these systems for treatment, unmet needs from the end user perspective, availability of alternatives in the market, and limitations faced by users of 6mv single-photon radiotherapy systems.
Our analysts helped the client to understand the market potential as well as the high impact of these systems in developing countries. Further, we also helped the client build an understanding of the competitive landscape in this market. Our client services team helped the client to devise a differentiated product offering and forge suitable alliances to help them win in these developing markets.
Revenue Shifts Identified
Stereotactic radiotherapy, brachytherapy, and radioimmunotherapy are some of the emerging areas in radiation oncology space; that is expected to shift the user preference in coming decade owing to their lower relapse rate and early patient recovery. This is further supported by growing reimbursement coverage for cancer therapies across major healthcare markets worldwide.
Recent developments in the field of biomarkers have resulted in more accurate and early cancer detection. This is also contributing to greater accuracy of radiation-based treatment with accurate identification of cancer cells resulting in lower risk to healthy cells, leading to early patient recovery and greater clinical success rate.
Additive manufacturing techniques are currently being explored by various stakeholders to develop personalized products for radiation oncology. This is expected to be augmented by related developments in CT & MRI guided radiation procedures.
Revenue Impact (RI)
Our insights helped the client to expand into 6mV single-photon radiotherapy systems market resulting in an incremental revenue of USD 50 million by 2022
See how future revenue sources change for these companies
Our client, a leading provider of analytical laboratory instruments and software, engaged MarketsandMarkets to grow revenues. We offered in-depth intelligence into the i ....Read More
One of the leading players in the power supply market, engaged MarketsandMarkets to secure and grow revenue streams. We offered detailed intelligence into the shifting r ....Read More
A leading vendor of professional cleaning robots engaged MarketsandMarkets to grow and secure revenue streams. For this purpose, our team offered detailed insights into ....Read More
Our client, a UK-based medical device manufacturing company, wanted to grow its revenues. For this purpose, our team offered actionable insights into the interconnection ....Read More
Our client, a leading provider of analytical laboratory instruments and software, engaged MarketsandMarkets to grow its revenues. Our team offered in-depth intelligence ....Read More
The client, a leading healthcare company, was interested in growing revenues. Our team offered detailed insights on the opportunities in the hemodialysis and peritoneal ....Read More
Our client, a dental implant manufacturer based in Asia, wanted to grow its revenues. We offered in-depth intelligence into the connected ecosystems of our client, clien ....Read More
Our client, a nonprofit biomedical research institute, was keen on building a substantive business from in-vivo toxicology testing services in North America and Europe. ....Read More
Our client, one of the key players in the therapeutic apheresis market, engaged MarketsandMarkets to grow revenues. We defined and solved a series of problems for the cl ....Read More
Our client engaged MarketsandMarkets to grow revenues. For this purpose, we offered insights into the market value of 6mV single-photon radiotherapy systems in developin ....Read More
The client, a leading player in the neonatal critical care devices and breast pump market, was keen to strengthen its market position and grow revenues. For this purpos ....Read More
Our client, a top-20 global antimicrobial susceptibility testing market leader, engaged MarketsandMarkets to secure revenue streams. Our team offered a comprehensive vie ....Read More
Our client, a top-ten global technology infrastructure leader, was keen on increasing its revenues. It engages MarketsandMarkets for insights and roadmap to secure new g ....Read More
Our client engaged MarketsandMarkets to increase its revenues. For this purpose, we offered insights into the shifting revenue sources of client’s clients and their clie ....Read More
Our client, a key provider of hernia repair surgery, engaged MarketsandMarkets to increase revenues and identify growth opportunities. The client was keen on understandi ....Read More
Our client, an emerging medical device company, was planning to grow its revenues with the launch of an innovative CO2 monitoring device in the US. It engaged Marketsand ....Read More
Our client, a leading global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, engaged Mark ....Read More